Supraventricular tachycardia (SVT) is frequently encountered by health care clinicans.1,2 Therefore, it is imperative for clinicians to recognize the clinical manifestations of SVT and choose the best test to establish a diagnosis. Available tests include a Holter monitor (if symptoms occur daily or every other day), ambulatory electrocardiographic monitoring (if symptoms occur weekly or biweekly), or an implantable loop recorder (if symptoms are infrequent or a diagnosis could not be established with noninvasive monitoring despite ongoing symptoms). Long-term management of SVT includes pharmacologic therapy, catheter ablation, or observation. The selection of long-term treatment depends on several factors, including the frequency and severity of the patient’s symptoms, the presence of structural heart disease, the presence of noncardiac comorbidities, and the patient’s preferences.1,2
Al-Khatib SM, Page RL. Ongoing Management of Patients With Supraventricular Tachycardia. JAMA Cardiol. 2017;2(3):332–333. doi:10.1001/jamacardio.2016.5085
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: